The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a substantial burden on patients and health care services. Early rhythm control may effectively reduce irreversible atrial remodeling and prevent AF-related deaths, heart failure, and strokes in high-risk patients. It has the potential to halt progression and potentially save patients from years of symptomatic AF; therefore, it should be offered more widely.

Editors

Editor-in-Chief
Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Authors
A. John Camm, MD

Important Dates

Date of Release: May 9, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: May 8, 2023